Bimatoprost is a prostaglandin analog used topically to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure by increasing the outflow of aqueous fluid from the eyes. More
Bimatoprost is a prostaglandin analog used topically to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure by increasing the outflow of aqueous fluid from the eyes.
Bimatoprost- prostaglandin analog used topically to control the progression of glaucoma and in the management of ocular hypertension.
Lumigan; Latisse; AGN 192024
Bitoma, Careprost, Careprost Plus, Ganfort, Lumigan
(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl]-N-ethylhept-5-enamide
A synthetic structural analog of prostaglandin with ocular hypotensive activity, it mimics selectively the effects of naturally occurring substances, prostamides. Elevated IOP presents a major risk factor for glaucomatous field loss. This drug lowers intraocular pressure (IOP) in humans. The higher the level of IOP, the greater the likelihood of optic nerve damage and visual field loss.
Bimatoprost 0.1 mg/mL or Bimatoprost 0.3 mg/mL ophthalmic solution.
Indicated for open angle glaucoma and for intra ocular pressure.
Bimatoprost ophthalmic solution may cause vision changes, photophobia, itching/pain with redness of eyes, watery eyes, eye discomfort and dizziness, burning or stinging of eyes.
Hypersensitivity
Store at 20-25°C.
415.5656
C25H37NO4
155206-00-1
Bimatoprost ophthalmic solution may cause gradual brown discoloration of eyes or eyelids colour with increased growth of eyelashes. Colour change could be irreversible even after years of treatment discontinuation. Avoid overdose of Bimatoprost. It may result in drug tolerance.
